Trillium Therapeutics Reports Annual Financial and Operating Results Mar 10, 2020 07:00AM
Trillium Therapeutics (TRIL) Adds Paul Walker to Board Feb 7, 2020 07:18AM
Trillium Therapeutics Announces Changes to Its Board of Directors Feb 7, 2020 07:00AM
Trillium Closes US$117 Million Public Offering of Common Shares and Series II Non-Voting Convertible First Preferred Shares Jan 29, 2020 07:00AM